Bionyeri has seed funding from our co-founder and Chairman, M. Eng Liang Tan. We are now seeking Series A investment to commercialise our R&D.
Contact us for a copy of our Pitch Deck or find out more about our fundraising objectives.
We’re enabling the next leap of intelligence in the development of natural products for pain from our PC2 accredited laboratory.
Bionyeri has its own AI algorithms for optimising natural product formulations for pain and inflammation.
Since inception we have:
Developed our own AI algorithms for optimisation product development for pain and inflammation applicable to Australia and Indonesia.
Established trade marks for Bionyeri in Australia and Indonesia
Trade-marked Medi-Flamme, our natural, Bionyeri-developed cream, for inflammation and muscle pain.
Set-up the development of AI-driven biobanks in for cancer patients in Indonesia.
Been the first Australian company to sign an NDA and research collaboration with BRIN (Indonesia’s CSIRO) specifically for research into kratom as a future
In less than 12 months we built a PC2 facility and conducted our first experiments.
Our pipeline of development is constantly evolving. Contact us to find out more.
We are a state-of-the-art R&D facility using bioactive and plant extracts, our own AI and enhanced drug delivery to create a new generation of products to aid pain relief in a range of human health conditions.
Copyright © 2024 | Bionyeri. All Rights Reserved.
Web Design by YEWS | Privacy Policy | Terms of Use |
